Login to Your Account


SHANGHAI – Newly created oncology biotech, CBT Pharmaceuticals, of Santa Clara, Calif., has received $9.75 million in series A financing from venture investors led by Orbimed Healthcare Fund Management Asia, with an additional $2 million available in warrants.

Chasing improved safety and decreased brain damage for stroke sufferers, Nuvox Pharma LLC is preparing for a fourth quarter start to a phase Ib study of NVX-208, one of multiple oxygen therapeutics the company is advancing.

SHANGHAI – KBP Biosciences (China) Inc. is the brainchild of Zhenhua Huang, a Chinese serial entrepreneur that first found success with his earlier effort, Xuanzhu Pharma.

More Newco News Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: